期刊文献+

肝移植术后受体ICU真菌感染的临床分析 被引量:7

Clinical analysis of fungal infections in liver transplant recipients in ICU
在线阅读 下载PDF
导出
摘要 目的探讨导致原位肝移植术后重症监护病房(ICU)真菌感染的病原学特征和临床高危因素.方法回顾我院2000-11/2006-01施行的102例次原位肝移植临床资料,对可能导致术后真菌感染的围手术期相关因素进行分析,筛选临床高危因素.结果肝移植术后平均ICU留住时间为11.0d(7~23d),其间真菌感染的发病率为16%(16/102),平均发病时间为术后11.8d(6~18d).主要致病菌为白色念珠菌,约占75%,发生部位以肺部(73%)和血液(19%)多见.多因素Logistic回归分析显示术前UNOS评分、术后中心静脉导管留置时间以及术后细菌、病毒等其他感染是诱发肝移植术后受体真菌感染的高危因素.结论真菌感染是发生于肝移植术后ICU内重要并发症.白色念珠菌是最常见的致病菌.针对以上高危因素及早采取合理、有效的防治措施是减少ICU真菌感染的关键. AIM: To study the fungal spectrum and high risk factors associated with fungal infection in the intensive care unit ( ICU ) after orthotopic liver transplantation ( OLTx ). METHODS: One hundred and two consecutive OLTx in 100 recipients performed from November 2000 to January 2006 were included in the study. Their pre-surgical, surgical and post-surgical variables were retrospectively evaluated using multivariate logistic regression model to identify the significant risk factors. RESULTS: The mean ICU stay was 11.0 d (7 -23 d). Out of the 102 OLTx, 16 ( 16% ) developed 29 positive cultures in our ICU and the mean time interval from transplantation to the development of fungal infection was 11.8 d (6 - 18 d). The most common pathogen was Candida albicans (75%) and the common primary sites were the lungs (73%) and blood ( 19% ). The risk factors for fungal infections included preoperative UNOS status, postoperative detained central venous catheter and other infective complications. CONCLUSION: Fungal infections are a major complication in ICU following OLTx, with Candida albicans being the most common pathogen. Surveillance for the high risk factors and earlier antifungal prophylactic treatment is the key to decrease the incidence of postoperative fungal infections.
出处 《第四军医大学学报》 CAS 北大核心 2006年第19期1786-1788,共3页 Journal of the Fourth Military Medical University
关键词 肝移植 真菌感染 危险因素 liver transplantation fungal infection risk factors
  • 相关文献

参考文献10

  • 1黎丽芬,管向东,陈娟,陈规划,蔡常洁,杨扬.肝移植后受体真菌感染的易感因素分析[J].中华医院感染学杂志,2005,15(1):33-36. 被引量:16
  • 2<应用抗菌药物防治外科感染的指导意见>撰写协作组.应用抗菌药物防治外科感染的指导意见(草案)Ⅶ[J].中华外科杂志,2003,41(12):944-945. 被引量:178
  • 3Rabkin JM,Oroloff SL,Corless CL,et al.Association of fungal infection and increased mortality in liver transplant recipients[J].Am J Surg,2000,179(5):426-430.
  • 4Pappas PG,Andes D,Schuster M,et al.Invasive fungal infections in low-risk liver transplant recipients:A multi-center prospective observational study[J].Am J Transplant,2006,6(2):386-391.
  • 5Badiee P,Kordbacheh P,Alborzi A,et al.Fungal infections in solid organ recipients[J].Exp Clin Transplant,2005,3(2):385-389.
  • 6Swoboda-Kopec E,Kawecki D,Wroblewska M,et al.Epidemiology and susceptibility to antifungal agents of fungi isolated from clinical specimens from patients hospitalized in the Department of General and Liver Surgery of the Medical University of Warsaw[J].Transplant Proc,2003,35(6):2298-2303.
  • 7Morgan J,Wannemuehler KA,Marr KA,et al.Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation:Interim results of a prospective multicenter surveillance program[J].Med Mycol,2005,43(Suppl 1):S49-S58.
  • 8Biancofiore G,Bindi ML,Baldassarri R,et al.Antifungal prophylaxis in liver transplant recipients:A randomized placebo-controlled study[J].Transpl Int,2002,15(7):341-347.
  • 9Cueto G,Trigo P,Arata A,et al.Evaluation of Prognostic Factors for Early Infection in Liver Transplantation[J].Transplant Proc,1999,31(7):3061-3062.
  • 10Dockrell DH,Mendez JC,Jones M,et al.Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients[J].Transplantation,1999,67(3):399-403.

二级参考文献8

  • 1Collins LA, Samore MH, Roberts MS, et al. Risk factors for invasive fungal injections complicating orthotopic liver trans-plantation[J]. JID, 1994, 170(9): 644-652.
  • 2Drew JW, Emmanouilides C, Ronald WB. Infections in liver transplant recipients[J]. Clin Infect Dis, 1995, 21(5): 1077-1091.
  • 3Hadley S, Karchuner AW. Fungal infections in solid organ transplant recipients[J]. Inject Dis Clin North Am, 1995, 9(4): 1045-1074.
  • 4John M, Rabkin MD, Susan L, et al. Association of fungal in-fection and increased mortality in liver transplant recipients[J].Am J Surg, 2000, 179(5): 426-430.
  • 5Winston DJ, Pakrasi A, Busuttil RB. Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind,placebo-controlled trial[J]. Ann Intern Med, 1999, 131(10):729-737.
  • 6李革,卢仙娥,邓济苏,王从容,曹何,余显书.重症监护室获得性感染与传播机制研究[J].中华医院感染学杂志,2000,10(6):404-406. 被引量:168
  • 7李宁,李有信,冯喆.清洁手术预防性应用抗生素1∶1病例对照研究[J].中华医院感染学杂志,2001,11(4):247-248. 被引量:29
  • 8史宪杰,冯玉泉,顾万清,周宁新,黄晓强,张文智,黄志强.肝脏移植术后受体感染性并发症的防治[J].中华医院感染学杂志,2002,12(8):569-570. 被引量:8

共引文献192

同被引文献106

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部